Kura Oncology Inc (NASDAQ: KURA) on Friday, soared 0.58% from the previous trading day, before settling in for the closing price of $8.68. Within the past 52 weeks, KURA’s price has moved between $8.42 and $24.17.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The company achieved an average annual earnings per share of -14.67%. With a float of $65.25 million, this company’s outstanding shares have now reached $77.75 million.
The extent of productivity of a business whose workforce counts for 142 workers is very important to gauge. In terms of profitability, gross margin is 48.82%, operating margin of -17126.14%, and the pretax margin is -15555.28%.
Kura Oncology Inc (KURA) Insider Updates
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Kura Oncology Inc is 16.10%, while institutional ownership is 97.61%. The most recent insider transaction that took place on Nov 18 ’24, was worth 8,434. In this transaction Chief Operating Officer of this company sold 526 shares at a rate of $16.03, taking the stock ownership to the 23,184 shares. Before that another transaction happened on Nov 18 ’24, when Company’s Officer proposed sale 526 for $15.99, making the entire transaction worth $8,410.
Kura Oncology Inc (KURA) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.67 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -14.67% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 19.93% during the next five years compared to -3.94% drop over the previous five years of trading.
Kura Oncology Inc (NASDAQ: KURA) Trading Performance Indicators
Kura Oncology Inc (KURA) is currently performing well based on its current performance indicators. A quick ratio of 11.47 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.36, a number that is poised to hit -0.57 in the next quarter and is forecasted to reach -2.00 in one year’s time.
Technical Analysis of Kura Oncology Inc (KURA)
The latest stats from [Kura Oncology Inc, KURA] show that its last 5-days average volume of 1.43 million was superior to 1.26 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 30.91%. Additionally, its Average True Range was 0.51.
During the past 100 days, Kura Oncology Inc’s (KURA) raw stochastic average was set at 2.36%, which indicates a significant decrease from 19.37% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 38.07% in the past 14 days, which was lower than the 81.44% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $12.95, while its 200-day Moving Average is $18.39. Now, the first resistance to watch is $8.85. This is followed by the second major resistance level at $8.97. The third major resistance level sits at $9.10. If the price goes on to break the first support level at $8.61, it is likely to go to the next support level at $8.48. Assuming the price breaks the second support level, the third support level stands at $8.36.
Kura Oncology Inc (NASDAQ: KURA) Key Stats
Market capitalization of the company is 682.79 million based on 77,764K outstanding shares. Right now, sales total 0 K and income totals -152,630 K. The company made 0 K in profit during its latest quarter, and -54,400 K in sales during its previous quarter.
